These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23219351)

  • 1. Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations.
    Burke G; Hiscock A; Klein A; Niks EH; Main M; Manzur AY; Ng J; de Vile C; Muntoni F; Beeson D; Robb S
    Neuromuscul Disord; 2013 Feb; 23(2):170-5. PubMed ID: 23219351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salbutamol therapy in congenital myasthenic syndrome due to DOK7 mutation.
    Lorenzoni PJ; Scola RH; Kay CS; Filla L; Miranda AP; Pinheiro JM; Chaouch A; Lochmüller H; Werneck LC
    J Neurol Sci; 2013 Aug; 331(1-2):155-7. PubMed ID: 23790237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective Treatment With Albuterol in DOK7 Congenital Myasthenic Syndrome in Children.
    Tsao CY
    Pediatr Neurol; 2016 Jan; 54():85-7. PubMed ID: 26552645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Dok7 congenital myasthenic syndrome responsive to salbutamol.
    Maramattom BV; Patil R; Thomas J
    Neurol India; 2014; 62(3):313. PubMed ID: 25033858
    [No Abstract]   [Full Text] [Related]  

  • 5. DOK7 limb-girdle myasthenic syndrome mimicking congenital muscular dystrophy.
    Mahjneh I; Lochmüller H; Muntoni F; Abicht A
    Neuromuscul Disord; 2013 Jan; 23(1):36-42. PubMed ID: 22884442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
    Lashley D; Palace J; Jayawant S; Robb S; Beeson D
    Neurology; 2010 May; 74(19):1517-23. PubMed ID: 20458068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limb girdle weakness responding to salbutamol: an Indian family with DOK7 mutation.
    Khadilkar S; Bhutada A; Nallamilli B; Hegde M
    Indian Pediatr; 2015 Mar; 52(3):243-4. PubMed ID: 25849006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOK7 congenital myasthenic syndrome.
    Palace J
    Ann N Y Acad Sci; 2012 Dec; 1275():49-53. PubMed ID: 23278577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COLQ-Related Congenital Myasthenic Syndrome and Response to Salbutamol Therapy.
    Padmanabha H; Saini AG; Sankhyan N; Singhi P
    J Clin Neuromuscul Dis; 2017 Mar; 18(3):162-163. PubMed ID: 28221310
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of salbutamol on neuromuscular junction function and structure in a mouse model of DOK7 congenital myasthenia.
    Webster RG; Vanhaesebrouck AE; Maxwell SE; Cossins JA; Liu W; Ueta R; Yamanashi Y; Beeson DMW
    Hum Mol Genet; 2020 Aug; 29(14):2325-2336. PubMed ID: 32543656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-2 Adrenergic Receptor Agonists Enhance AChR Clustering in C2C12 Myotubes: Implications for Therapy of Myasthenic Disorders.
    Clausen L; Cossins J; Beeson D
    J Neuromuscul Dis; 2018; 5(2):231-240. PubMed ID: 29865088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DOK7 congenital myasthenic syndrome responsive to oral salbutamol.
    Tayade K; Salunkhe M; Agarwal A; Radhakrishnan DM; Srivastava AK
    QJM; 2022 May; 115(5):323-324. PubMed ID: 35092298
    [No Abstract]   [Full Text] [Related]  

  • 13. Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol.
    Finlayson S; Spillane J; Kullmann DM; Howard R; Webster R; Palace J; Beeson D
    Muscle Nerve; 2013 Feb; 47(2):279-82. PubMed ID: 23281026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DOK7 myasthenic syndrome with subacute adult onset during pregnancy and partial response to fluoxetine.
    Santos M; Cruz S; Peres J; Santos L; Tavares P; Basto JP; Salgado V; Valverde AH
    Neuromuscul Disord; 2018 Mar; 28(3):278-282. PubMed ID: 29395672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK.
    Gallenmüller C; Müller-Felber W; Dusl M; Stucka R; Guergueltcheva V; Blaschek A; von der Hagen M; Huebner A; Müller JS; Lochmüller H; Abicht A
    Neuromuscul Disord; 2014 Jan; 24(1):31-5. PubMed ID: 24183479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β2-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure.
    Vanhaesebrouck AE; Webster R; Maxwell S; Rodriguez Cruz PM; Cossins J; Wickens J; Liu WW; Cetin H; Cheung J; Ramjattan H; Palace J; Beeson D
    Brain; 2019 Dec; 142(12):3713-3727. PubMed ID: 31633155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DOK7 congenital myasthenic syndrome: case series and review of literature.
    Ziaadini B; Ghaderi Yazdi B; Dirandeh E; Boostani R; Karimi N; Panahi A; Kariminejad A; Fadaee M; Ahangari F; Nafissi S
    BMC Neurol; 2024 Jun; 24(1):211. PubMed ID: 38907197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome.
    McMacken GM; Spendiff S; Whittaker RG; O'Connor E; Howarth RM; Boczonadi V; Horvath R; Slater CR; Lochmüller H
    Hum Mol Genet; 2019 Jul; 28(14):2339-2351. PubMed ID: 31220253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations.
    Rodríguez Cruz PM; Cossins J; Estephan EP; Munell F; Selby K; Hirano M; Maroofin R; Mehrjardi MYV; Chow G; Carr A; Manzur A; Robb S; Munot P; Wei Liu W; Banka S; Fraser H; De Goede C; Zanoteli E; Conti Reed U; Sage A; Gratacos M; Macaya A; Dusl M; Senderek J; Töpf A; Hofer M; Knight R; Ramdas S; Jayawant S; Lochmüller H; Palace J; Beeson D
    Brain; 2019 Jun; 142(6):1547-1560. PubMed ID: 31081514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations.
    Schara U; Barisic N; Deschauer M; Lindberg C; Straub V; Strigl-Pill N; Wendt M; Abicht A; Müller JS; Lochmüller H
    Neuromuscul Disord; 2009 Dec; 19(12):828-32. PubMed ID: 19837590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.